药品上市许可持有人制度下药品上市后监管风险分析及监管对策研究
施绿燕, 柳涛, 朱佳娴
Regulatory Risk Analysis and Countermeasures Study of Post-Marketing Drugs Under Marketing Authorization Holder System
Shi Lvyan, Liu Tao, Zhu Jiaxian
中国药事
.
2019, (8): 851
-856
.
DOI: 10.16153/j.1002-7777.2019.08.002
